Indoxyl Sulfate Promotes Arterial Thrombosis in Rat Model via Increased Levels of Complex TF/VII, PAI-1, Platelet Activation as Well as Decreased Contents of SIRT1 and SIRT3
Patients suffering from chronic kidney disease (CKD) are at a 20-fold higher risk of dying due to cardiovascular diseases (CVDs), primarily thrombosis following vascular injury. CKD is connected with retention of uremic toxins, especially indoxyl sulfate (IS), which are currently considered as a non...
Main Authors: | Malgorzata Karbowska, Tomasz W. Kaminski, Beata Znorko, Tomasz Domaniewski, Tomasz Misztal, Tomasz Rusak, Anna Pryczynicz, Katarzyna Guzinska-Ustymowicz, Krystyna Pawlak, Dariusz Pawlak |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2018-11-01
|
Series: | Frontiers in Physiology |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fphys.2018.01623/full |
Similar Items
-
The Uremic Toxin Indoxyl Sulfate Accelerates Thrombotic Response after Vascular Injury in Animal Models
by: Malgorzata Karbowska, et al.
Published: (2017-07-01) -
SIRT1 and SIRT2 Activity Control in Neurodegenerative Diseases
by: Ramu Manjula, et al.
Published: (2021-01-01) -
SIRT1 and SIRT2 Modulators: Potential Anti-Inflammatory Treatment for Depression?
by: Yuqing Zhang, et al.
Published: (2021-02-01) -
Active regulator of SIRT1 is required for cancer cell survival but not for SIRT1 activity
by: John R. P. Knight, et al.
Published: (2013-01-01) -
Is SIRT6 Activity Neuroprotective and How Does It Differ from SIRT1 in This Regard?
by: Bor L. Tang, et al.
Published: (2017-06-01)